<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="16" ids="53704">APO</z:chebi>-1 is a 48-Kd transmembrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> identical to the Fas antigen and belongs to the nerve growth factor (NGF)/<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) receptor family of surface molecules </plain></SENT>
<SENT sid="1" pm="."><plain>Cross-linking of <z:chebi fb="16" ids="53704">APO</z:chebi>-1 induces apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> in sensitive cells </plain></SENT>
<SENT sid="2" pm="."><plain>We show here that <z:chebi fb="16" ids="53704">APO</z:chebi>-1 is an activation molecule on B cells </plain></SENT>
<SENT sid="3" pm="."><plain>It was induced/enhanced on dense and buoyant tonsillar B cells, respectively, through surface Ig cross-linking in combination with interleukin-2 or by interferon-gamma together with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha </plain></SENT>
<SENT sid="4" pm="."><plain>These conditions also increased the amount of intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (CD54) on these cells </plain></SENT>
<SENT sid="5" pm="."><plain>Epstein-Barr virus transformants of peripheral B cells coexpressed <z:chebi fb="16" ids="53704">APO</z:chebi>-1 and CD54 at very high levels </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistologically, Apo-1 was detectable at low levels in a subpopulation of follicle center B blasts and, at higher levels, in sinusoidal B cells </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="16" ids="53704">APO</z:chebi>-1 was undetectable in follicular mantle B cells and plasma cells </plain></SENT>
<SENT sid="8" pm="."><plain>In isolated tonsillar B cells, <z:chebi fb="16" ids="53704">APO</z:chebi>-1 was expressed in CD10+ follicle center cells </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:hpo ids='HP_0011009'>acute</z:hpo> B lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> B lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, <z:chebi fb="16" ids="53704">APO</z:chebi>-1 and CD54 molecules were immunohistochemically undetectable </plain></SENT>
<SENT sid="10" pm="."><plain>Coordinate expression of these antigens was found in mediastinal B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The mode of <z:chebi fb="16" ids="53704">APO</z:chebi>-1 and CD54 expression was correlated in follicle center cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (P &lt; .0019), but less stringently in hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>No association was found in <z:hpo ids='HP_0011857'>plasmacytomas</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>This was in line with the differential expression of these molecules found in reactive plasma cells </plain></SENT>
<SENT sid="14" pm="."><plain>Expression of <z:chebi fb="16" ids="53704">APO</z:chebi>-1 in B cells of different stages of differentiation and, correspondingly, in certain B-cell <z:hpo ids='HP_0002664'>neoplasias</z:hpo> might suggest a role of this molecule in the induction of B-cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="15" pm="."><plain>This function might be influenced by CD54 and CD54-mediated signals </plain></SENT>
</text></document>